Trials
1 active
1 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- Tested for
- HPV (Human Papillomavirus)-Associated, Genital Warts
- Main trialPhase 2
- “Phase II, a randomized, double-blind, placebo-controlled clinical trial to evaluate the effectiveness and recurrence of genital warts by combination of CO2 laser and Geniwa gel compared to laser CO2 combined with gel placebo. The clinical trial is conducted at National Dermatology Hospital, Hanoi, Vietnam.”In the company’s words, NCT07698886 on ClinicalTrials.gov
Other drugs for Genital Warts
- 9-valent Human Papillomavirus Recombinant VaccineShanghai Bovax Biotechnology Co., Ltd. · Phase 3
- V503Merck & Co. · Phase 3
- Recombinant Nonavalent Human Papillomavirus VaccineBeijing Health Guard Biotechnology, Inc · Phase 3
- 15-valent recombinant human papillomavirus vaccineShanghai Bovax Biotechnology Co., Ltd. · Phase 2
Coming up1
- 15 Aug 2027Phase 2 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials1
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Recruiting | 15 Aug 2027 | Treatment of Recurrent Genital Warts by Combination of CO2 Laser and Geniwa Gel |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026